Opinion

Video

Comparing the ACC/AHA and ESC/EAS Cholesterol Management Guidelines

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

The panel compares the ACC/AHA cholesterol guidelines with the ESC/EAS guidelines and provides thoughts on how educational initiatives can be improved to increase familiarity and implementation.

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
LDL (Bad) lipoprotein (cholesterol) in the blood flow – Closeup view 3d illustration
April 18th 2025

Lepodisiran Reduces Lipoprotein(a) By Nearly 94% in Adults With Elevated Levels of Lp(a)

Luke Halpern, Assistant Editor
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
Low HDL-C, Triglyceride Levels in Late Life Independently Associated With Alzheimer Disease and Related Dementias
April 3rd 2025

Low HDL-C, Triglyceride Levels in Late Life Independently Associated With Alzheimer Disease and Related Dementias

Luke Halpern, Assistant Editor
Hyperlipidemia or arteriosclerosis. Blocked artery concept and human blood vessel as a disease with cholesterol fat buildup clogging. Clogged arteries, Cholesterol plaque in the artery.
March 28th 2025

Very Low LDL-C Achieved With Evolocumab Not Associated With Long-Term Cognitive Impairment

Luke Halpern, Assistant Editor
High Low-Density Lipoprotein Cholesterol Associated With Improved Survival in Acutely Decompensated Heart Failure
March 27th 2025

High Low-Density Lipoprotein Cholesterol Associated With Improved Survival in Acutely Decompensated Heart Failure

Luke Halpern, Assistant Editor
Cholesterol plaque in artery
March 21st 2025

Elevated Non-HDL Cholesterol a Stronger Indicator of Major Cardiovascular Events Compared With LDL-C

Luke Halpern, Assistant Editor